Hemodynamic Effects of Sacubitril-Valsartan in Heart Failure with Reduced-Ejection Fraction: Are All Doses Created Equal?

被引:0
|
作者
Masetti, M. [1 ]
Corazza, F. [1 ]
Giovannini, L. [1 ]
Russo, A. [1 ]
Prestinenzi, P. [1 ]
Boschi, S. [1 ]
Potena, L. [1 ]
机构
[1] Univ Bologna, Cardiovasc Dept, Bologna, Italy
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
108
引用
收藏
页码:S53 / S53
页数:1
相关论文
共 50 条
  • [41] Safety and efficacy of sacubitril-valsartan initiation during and after acute decompensated heart failure with reduced ejection fraction
    Tan, C. T.
    Koh, K. T.
    Onn, Y. Y.
    Ho, K. H.
    Said, A.
    Amin, Mohd N. H.
    Shu, F. E. P.
    Khiew, N. Z.
    Cham, Y. L.
    Fong, A. Y. Y.
    Ong, T. K.
    Eng, S. Y.
    Lee, Z. Y.
    Madzlan, N.
    EUROPEAN HEART JOURNAL, 2020, 41 : 19 - 19
  • [42] Cost-Effectiveness of Sacubitril-Valsartan in Patients Who Have Heart Failure With Reduced Ejection Fraction RESPONSE
    Sandhu, Alexander T.
    Ollendorf, Daniel A.
    Chapman, Richard H.
    Pearson, Steven D.
    Heidenreich, Paul A.
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (08) : 607 - 608
  • [43] Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea
    Pelaia, Corrado
    Armentaro, Giuseppe
    Volpentesta, Mara
    Mancuso, Luana
    Miceli, Sofia
    Caroleo, Benedetto
    Perticone, Maria
    Maio, Raffaele
    Arturi, Franco
    Imbalzano, Egidio
    Andreozzi, Francesco
    Perticone, Francesco
    Sesti, Giorgio
    Sciacqua, Angela
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [44] The Effects of Sacubitril/Valsartan on Clinical, Biochemical and Echocardiographic Parameters in Patients with Heart Failure with Reduced Ejection Fraction: The "Hemodynamic Recovery"
    Romano, Giuseppe
    Vitale, Giuseppe
    Ajello, Laura
    Agnese, Valentina
    Bellavia, Diego
    Caccamo, Giuseppa
    Corrado, Egle
    Di Gesaro, Gabriele
    Falletta, Calogero
    La Franca, Eluisa
    Mina, Chiara
    Storniolo, Salvatore Antonio
    Sarullo, Filippo Maria
    Clemenza, Francesco
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (12)
  • [45] THE EFFECTS OF SACUBITRIL/VALSARTAN ON CLINICAL, BIOCHEMICAL AND ECHOCARDIOGRAPHIC PARAMETERS IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: THE "HEMODYNAMIC RECOVERY"
    Romano, G.
    Ajello, L.
    Vitale, G.
    Bellavia, D.
    Sarullo, F.
    Clemenza, F.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G189 - G189
  • [46] Efficacy of Sacubitril-Valsartan in Patients with Reduced Left Ventricular Ejection Fraction
    Ueyama, Hiroki
    Kuno, Toshiki
    Briasoulis, Alexandros
    CIRCULATION, 2021, 144
  • [47] Efficacy of Sacubitril-Valsartan in Patients With Reduced Left Ventricular Ejection Fraction
    Briasoulis, Alexandros
    Kuno, Toshiki
    Ueyama, Hiroki
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 153 : 150 - 152
  • [48] Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction
    Mohebi, Reza
    Liu, Yuxi
    Felker, G. Michael
    Prescott, Margaret F.
    Ward, Jonathan H.
    Pina, Ileana L.
    Butler, Javed
    Solomon, Scott D.
    Januzzi, James L.
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (12) : 1673 - 1682
  • [49] Economic evaluation of sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction
    Stafylas, P.
    Farmakis, D.
    Giamouzis, G.
    Hatzikou, M.
    Kourlaba, G.
    Papatsouma, I.
    Maniadakis, N.
    EUROPEAN HEART JOURNAL, 2016, 37 : 730 - 731
  • [50] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Rex C. Liu
    American Journal of Cardiovascular Drugs, 2018, 18 : 473 - 482